Author: Morgridge Institute for Research

In our post-COVID world, science must be our new frontier

Writing in The Hill, Morgridge CEO Dr. Brad Schwartz provides insight and context for scientific discovery as a foundation for economic prosperity. As the United States looks to science to help us get past the COVID-19 pandemic, we would be well advised to also look back.

Detecting cellular diversity to sharpen personalized cancer treatments

Melissa Skala, a University of Wisconsin–Madison associate professor of biomedical engineering, and collaborators have used an approach called optical metabolic imaging (OMI) to effectively assess that heterogeneity and related treatment responses in organoids created with tissues from patients with breast cancer and pancreatic cancer.

The Power List 2020

Stem cell pioneer and Morgridge investigator James Thomson was named to the Power List 2020 for his contributions to advancing the field of medicine to save lives and improve the world.